Lenalidomide in combination with dexamethasone as first-line therapy in transplant-ineligible patients with Multiple Myeloma: Interim Results of the observational study FIRST-NIS.

H. Nückel; H.-J. Hurtz; H. Schulz; M. Schulze; M. Koenigsmann; T. Dechow; M. Merling; L. Houet; C. Vannier; K. Potthoff; 2019.

HemaSphere. 3():263–264, JUN 2019 DOI: 10.1097/01.HS9.0000560764.61601.55 Issn Print: 2572-9241